BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Straehla JP, Hajal C, Safford HC, Offeddu GS, Boehnke N, Dacoba TG, Wyckoff J, Kamm RD, Hammond PT. A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles. Proc Natl Acad Sci U S A 2022;119:e2118697119. [PMID: 35648828 DOI: 10.1073/pnas.2118697119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 E GA, A AC, M T, D Z, M K. From Cells to Organoids: The Evolution of Blood-Brain Barrier Technology for Modelling Drug Delivery in Brain Cancer. Adv Drug Deliv Rev 2023;:114777. [PMID: 36931346 DOI: 10.1016/j.addr.2023.114777] [Reference Citation Analysis]
2 Abballe L, Spinello Z, Antonacci C, Coppola L, Miele E, Catanzaro G, Miele E. Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors' Cancer Stem Cells: Current Knowledge and Future Perspectives. Pharmaceutics 2023;15. [PMID: 36839827 DOI: 10.3390/pharmaceutics15020505] [Reference Citation Analysis]
3 Chaulagain B, Gothwal A, Lamptey RNL, Trivedi R, Mahanta AK, Layek B, Singh J. Experimental Models of In Vitro Blood-Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective. Int J Mol Sci 2023;24. [PMID: 36769032 DOI: 10.3390/ijms24032710] [Reference Citation Analysis]
4 Cable J, Arlotta P, Parker KK, Hughes AJ, Goodwin K, Mummery CL, Kamm RD, Engle SJ, Tagle DA, Boj SF, Stanton AE, Morishita Y, Kemp ML, Norfleet DA, May EE, Lu A, Bashir R, Feinberg AW, Hull SM, Gonzalez AL, Blatchley MR, Montserrat Pulido N, Morizane R, McDevitt TC, Mishra D, Mulero-Russe A. Engineering multicellular living systems-a Keystone Symposia report. Ann N Y Acad Sci 2022;1518:183-95. [PMID: 36177947 DOI: 10.1111/nyas.14896] [Reference Citation Analysis]
5 Wan Z, Floryan MA, Coughlin MF, Zhang S, Zhong AX, Shelton SE, Wang X, Xu C, Barbie DA, Kamm RD. New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay. Adv Healthc Mater 2022;:e2201784. [PMID: 36333913 DOI: 10.1002/adhm.202201784] [Reference Citation Analysis]
6 Mayo LN, Kutys ML. Conversation before crossing: dissecting metastatic tumor-vascular interactions in microphysiological systems. Am J Physiol Cell Physiol 2022;323:C1333-44. [PMID: 36121131 DOI: 10.1152/ajpcell.00173.2022] [Reference Citation Analysis]
7 Shojaei S, Basso J, Amereh M, Alizadeh J, Dehesh T, De Silva Rosa S, Clark C, Hassan M, Tomczyk M, Cole L, Hatch G, Dolinsky V, Pasco C, Schibli D, Dhingra S, Srivastava A, Ravandi A, Vitorino R, Ghavami S, Akbari M. A multi-omics analysis of glioma chemoresistance using a hybrid microphysiological model of glioblastoma.. [DOI: 10.1101/2022.10.29.514383] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Palma-florez S, López-canosa A, Morales-zavala F, Castaño O, Kogan M, Samitier J, Lagunas A, Mir M. BBB-on-a-chip with Integrated micro-TEER for permeability evaluation of multi-functionalized gold nanorods against Alzheimer’s disease.. [DOI: 10.1101/2022.09.05.505851] [Reference Citation Analysis]
9 Peng B, Hao S, Tong Z, Bai H, Pan S, Lim KL, Li L, Voelcker NH, Huang W. Blood-brain barrier (BBB)-on-a-chip: a promising breakthrough in brain disease research. Lab Chip 2022. [PMID: 36004771 DOI: 10.1039/d2lc00305h] [Reference Citation Analysis]
10 Panovska D, De Smet F. Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome? IJMS 2022;23:8637. [DOI: 10.3390/ijms23158637] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Baka Z, Stiefel M, Figarol A, Godier C, Mallick A, Joubert O, Ashammakhi N, Gaffet E, Alem H. Cancer-on-chip technology: current applications in major cancer types, challenges and future prospects. Prog Biomed Eng 2022;4:032001. [DOI: 10.1088/2516-1091/ac8259] [Reference Citation Analysis]